Reverse Metabolomics: New Method Finds Biomarker for Inflammatory Bowel Disease

UC San Diego scientists’ debut “reverse metabolomics,” a groundbreaking approach to advancing microbiome research. They use the technique to discover hundreds of new human molecules, and a new biomarker and therapeutic target for inflammatory bowel disease

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks